Skip to main content

Advertisement

Table 1 Clinical and pathological characteristics of patients with HCC (n = 54)

From: Targeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta-catenin

Characteristics n % PRMT5 score P value
Gender
 Male 48 88.9 3.8542 0.369
 Female 6 11.1 3.3333  
Age (years)
 ≤50 17 31.5 3.2059 0.034
 >50 37 68.5 4.0135  
Tumor size (cm)
 ≤5 27 50 3.8611 0.573
 >5 27 50 3.6574  
TNM stage
 I 6 11.1 4.0833 0.259
 II 37 68.5 3.6757  
 III 11 20.4 8.8636